Skip to main content

Cancer Type

Lymphoma

Explore research, treatment approaches, biological mechanisms, and clinically relevant developments related to Lymphoma.

Cancer Type

Related Research

1

CD19 CAR-T Therapy Produces Durable Remission in TP53-Mutated, Triple-Refractory Burkitt Lymphoma

A 16-year-old male with TP53-mutated Burkitt lymphoma, initially misdiagnosed and refractory to three chemotherapy regimens, achieved complete metabolic response and remains in remission 30 months after CD19-directed CAR-T cell therapy (axicabtagene ciloleucel).